鼻咽癌IMRT后区域复发模式及其对ENI的启示
该回顾性研究分析了2012至2022年间145例鼻咽癌根治性IMRT后出现区域复发的患者,将复发淋巴结映射至治疗前影像并分类。结果显示95.2%的复发位于初诊受累区域内,区域外复发仅4.8%,5年总生存率为69.4%,提示区域复发以连续蔓延为主,为优化选择性颈照射提供参考。
要点
- 区域复发最常见于IIb区(55.1%),其次为IIa区(40.7%)和III区(26.9%)。
- 95.2%的复发位于初诊受累区域内,区域外复发仅4.8%且主要在下颈,未见跳跃转移。
- 5年总生存率为69.4%,接受挽救手术者达74.2%,支持对复发患者积极挽救治疗。
核心结论
- 鼻咽癌IMRT后区域复发主要局限于初诊受累区域,区域外复发罕见,提示复发以连续蔓延为主而非新发失败,可参考此模式优化选择性颈照射策略。
研究设计与样本
- 回顾性分析2012至2022年间145例鼻咽癌根治性IMRT后出现区域复发的患者,将复发淋巴结映射至治疗前影像,并分为初诊受累野内或野外复发。
主要发现
- 区域复发最常见于IIb区(55.1%),其次为IIa区(40.7%)、III区(26.9%)、IV区(17.2%)、Va区(11.7%)和Vb区(11.0%),咽后区(10.3%)和腮腺区(6.9%)较少受累。
- 95.2%的复发发生在初诊受累区域内,区域外复发仅4.8%且主要位于下颈,未见跳跃转移。
- 5年总生存率为69.4%,接受挽救手术的患者5年总生存率为74.2%。
临床怎么用
- 基于复发主要位于初诊受累区域且区域外复发罕见,优化选择性颈照射时可考虑对初诊未受累区域适当缩减照射范围。
- 对IMRT后区域复发患者,尤其是适合手术者,积极挽救治疗可获得较好的5年总生存率(74.2%)。
局限性
- 本研究为单中心回顾性分析,样本量145例,可能存在选择偏倚,结论需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patterns of regional failure after intensity-modulated radiotherapy (IMRT) provide crucial evidence for optimizing target delineation in nasopharyngeal carcinoma (NPC). However, the specific patterns of regional recurrence after IMRT for NPC remain to be fully elucidated to optimize elective neck irradiation (ENI). METHODS: A total of 145 patients with NPC who developed regional recurrence after definitive IMRT between 2012 and 2022 were retrospectively reviewed. Recurrent lymph nodes were mapped onto the original pretreatment imaging, and each failure was categorized as either within or outside the initially involved field. Overall survival (OS) was estimated using the Kaplan-Meier method. RESULTS: Regional recurrence most frequently occurred in level IIb (55.1%), followed by level IIa (40.7%), level III (26.9%), level IV (17.2%), levels Va (11.7%) and Vb (11.0%), with infrequent involvement of the retropharyngeal (10.3%) and parotid (6.9%) regions. Most failures (95.2%) occurred within initially involved areas, while out-involved field recurrences were rare (4.8%), predominantly in the lower neck, and no skip metastasis was observed, suggesting a pattern of contiguous spread rather than de novo failure. The 5-year overall survival rate was 69.4%, and 74.2% among patients who underwent salvage surgery. CONCLUSIONS: Regional recurrence after IMRT for NPC was mainly confined to initially involved areas, with out-involved-field recurrences being rare. These findings, combined with favorable outcomes following salvage treatment, serve as a valuable reference for optimizing ENI strategies. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Lin Y, Xu S, Yan L, et al. Patterns of regional recurrences after treatment of nasopharyngeal carcinoma. Radiat Oncol. 2026. PMID: 41840670. doi:10.1186/s13014-026-02827-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。